Previous close | 0.6069 |
Open | 0.6390 |
Bid | 0.5597 x 100 |
Ask | 0.6426 x 100 |
Day's range | 0.5710 - 0.6390 |
52-week range | 0.4390 - 11.9100 |
Volume | |
Avg. volume | 81,578 |
Market cap | 4.257M |
Beta (5Y monthly) | 0.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.8200 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 21.00 |
ATLANTA, May 14, 2024--Alzamend Neuro Announces Initial Closing of Private Placement; Investor Purchase Up to $25 Million of Preferred Shares; Proceeds for Clinical Trials
ATLANTA, May 09, 2024--Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of Up to $25 Million
ATLANTA, May 07, 2024--Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program